{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:20:05Z","timestamp":1793510405266,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007166","name":"JIangsu Education Department","doi-asserted-by":"publisher","award":["SY202411641640008"],"award-info":[{"award-number":["SY202411641640008"]}],"id":[{"id":"10.13039\/501100007166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX23_1843"],"award-info":[{"award-number":["SJCX23_1843"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108486","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:20:27Z","timestamp":1744870827000},"page":"108486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis, bioactivity, X-ray crystallography, and molecular docking studies of chrysin-1,3,5-triazine derivatives as anticancer agents"],"prefix":"10.1016","volume":"161","author":[{"given":"Xuan-Yi","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-en","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shuang-Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bo-Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hao-Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Qing-Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jing-Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs \u2014 microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108486_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104345","article-title":"Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis","volume":"104","author":"El-Azab","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136945","article-title":"Synthesis, characterization, anticancer, pharmacokinetics and molecular docking investigation of N (3)-alkyl incorporated-3-acetyl-4-hydroxycoumarin thiosemicarbazones and their copper(II) complexes","volume":"1299","author":"Shrestha","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108486_bb0020","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.31635\/ccschem.022.202101564","article-title":"Tumor-selective Cascade-amplified dual-prodrugs activation for synergistic oxidation-chemotherapy","volume":"4","author":"Xiao","year":"2022","journal-title":"CCS Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108486_bb0025","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in Cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108486_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/0095897022000001566","article-title":"Synthesis and Crystal Structure of trans-Dichloro(Ethylenediamine- -N,N\u2032-DI-3-Propionato)Platinum(IV) Monohydrate","volume":"55","author":"Kalu\u0110erovi\u0107","year":"2010","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0035","first-page":"11175","article-title":"Pt CBDCA-O(NH3)2(\u223c\u2212methionine-S): ring-opened adduct of the anticancer drug carboplatin (\"Paraplatin\")","volume":"116","author":"Barnham","year":"1994","journal-title":"Detection of a Similar Complex in Urine by NMR Spectroscopy"},{"key":"10.1016\/j.bioorg.2025.108486_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00684890","article-title":"Phase I study of oxaliplatin in patients with advanced cancer","volume":"25","author":"Extra","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1039\/C2DT31323E","article-title":"Cytotoxic platinum(ii) intercalators that incorporate 1R,2R-diaminocyclopentane","volume":"42","author":"Garbutcheon-Singh","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2025.108486_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/7653_2018_2","article-title":"Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer's Disease","author":"Ortiz","year":"2018","journal-title":"Multi-Target Drug Design Using Chem-Bioinformatic Approaches"},{"issue":"20","key":"10.1016\/j.bioorg.2025.108486_bb0055","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational Design of Multitarget-Directed Ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0060","doi-asserted-by":"crossref","unstructured":"R.-g. Fu, Y. Sun, W.-b. Sheng, D.-f. Liao, Designing multi-targeted agents: an emerging anticancer drug discovery paradigm, Eur. J. Med. Chem. 136 (2017) 195\u2013211.","DOI":"10.1016\/j.ejmech.2017.05.016"},{"issue":"28","key":"10.1016\/j.bioorg.2025.108486_bb0065","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.2174\/1568026617666170707124126","article-title":"Multi-targeted anticancer agents","volume":"17","author":"Zheng","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0070","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ejmech.2011.01.023","article-title":"Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica","volume":"46","author":"Prado-Prado","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1763839","article-title":"Discovery of new potential CDK2\/VEGFR2 type II inhibitors by fragmentation and virtual screening of natural products","author":"V\u00e1squez","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108486_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106957","article-title":"Discovery of plant-derived anti-tumor natural products: potential leads for anti-tumor drug discovery","volume":"142","author":"Hui","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108486_bb0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/14786419.2018.1493588","article-title":"Flavonoids: biological activities and therapeutic potential","volume":"34","author":"Juc\u00e1","year":"2018","journal-title":"Nat. Prod. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0090","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1039\/C4NJ02329C","article-title":"Synthesis, characterization and antioxidant activity of organoselenium and organotellurium compound derivatives of chrysin","volume":"39","author":"Fonseca","year":"2015","journal-title":"New J. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108486_bb0095","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1365-2672.2011.05170.x","article-title":"Chrysin protects mice from Staphylococcus aureus pneumonia","volume":"111","author":"Wang","year":"2011","journal-title":"J. Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2009.02.071","article-title":"Chrysin, a natural flavone, improves murine inflammatory bowel diseases","volume":"381","author":"Shin","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108486_bb0105","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.ejmech.2010.02.049","article-title":"A comparative study of flavonoid analogues on streptozotocin\u2013nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition","volume":"45","author":"Torres-Piedra","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108486_bb0110","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/ijms11052188","article-title":"Apoptotic effects of Chrysin in human Cancer cell lines","volume":"11","author":"Khoo","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108486_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.112142","article-title":"Synthesis, characterization, and anticancer potency of coumarin-derived thiosemicarbazones and their copper(II) complexes","volume":"161","author":"Shrestha","year":"2024","journal-title":"Inorg. Chem. Commun."},{"issue":"04","key":"10.1016\/j.bioorg.2025.108486_bb0120","first-page":"311","article-title":"Effects of herbal supplements on drug Glucuronidation","volume":"77","author":"Mohamed","year":"2010","journal-title":"Review of Clinical, Animal, andIn VitroStudies, Planta Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108486_bb0125","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/etm.2016.3518","article-title":"Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a","volume":"12","author":"Sun","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0130","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/cddis.2013.131","article-title":"Oroxylin a induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma","volume":"4","author":"Wei","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108486_bb0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bmcl.2015.11.072","article-title":"Anti-tumor activity evaluation of novel chrysin\u2013organotin compound in MCF-7 cells","volume":"26","author":"Xuan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108486_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2014.07.013","article-title":"Flavones: an important scaffold for medicinal chemistry","volume":"84","author":"Singh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108486_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bmcl.2005.09.009","article-title":"Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents","volume":"16","author":"Suresh Babu","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108486_bb0150","first-page":"499","article-title":"Positions of hydroxyl groups in Chrysin are critical for inhibiting plasminogen activator Inhibitor-1 release from human umbilical vein endothelial cells","volume":"12","author":"Ohkura","year":"2017","journal-title":"Nat. Prod. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108486_bb0155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1471-4159.2010.06952.x","article-title":"Inhibition of CCAAT\/enhancer binding protein \u03b4 expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects","volume":"115","author":"Gresa-Arribas","year":"2010","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108486_bb0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.foodchem.2012.02.166","article-title":"Evaluation of the structure\u2013activity relationship of flavonoids as antioxidants and toxicants of zebrafish larvae","volume":"134","author":"Chen","year":"2012","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108486_bb0165","article-title":"Anti-enterovirus 71 effects of Chrysin and its phosphate Ester","volume":"9","author":"Jhaveri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108486_bb0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s002130050353","article-title":"Endotoxin-induced reduction of social investigation by mice: interaction with amphetamine and anti-inflammatory drugs","volume":"132","author":"Fishkin","year":"1997","journal-title":"Psychopharmacology"},{"issue":"60","key":"10.1016\/j.bioorg.2025.108486_bb0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/np960581z","article-title":"Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-r in L-929 tumor cells","volume":"1","author":"Habtemariam","year":"1997","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108486_bb0180","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0968-0896(00)00102-4","article-title":"Flavonols from Heterotheca inuloides: Tyrosinase inhibitory activity and structural criteria","volume":"8","author":"Kubo","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(94)90103-1","article-title":"Possible anxiolytic effects of Chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea","volume":"47","author":"Wolfman","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/cncr.27742","article-title":"Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo","volume":"119","author":"Yu","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108486_bb0195","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202201159","article-title":"Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis","volume":"221","author":"Eskandari","year":"2022","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13193-022-01550-6","article-title":"Anti-cancer activity of Chrysin in Cancer therapy: a systematic review","volume":"13","author":"Salari","year":"2022","journal-title":"Indian J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0205","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbrc.2004.09.225","article-title":"Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells","volume":"325","author":"Woo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108486_bb0210","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3892\/or.2012.2016","article-title":"Induction of apoptosis by 7-piperazinethylchrysin in HCT-116 human colon cancer cells","volume":"28","author":"Ren","year":"2012","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0215","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bmc.2006.11.028","article-title":"Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives","volume":"15","author":"Zheng","year":"2007","journal-title":"Biorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108486_bb0220","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1021\/jm200981s","article-title":"Triazine-based Vanilloid 1 receptor Open Channel blockers: design, synthesis, evaluation, and SAR analysis","volume":"54","author":"Vidal-Mosquera","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106263","article-title":"Novel 6-amino-1,3,5-triazine derivatives as potent BTK inhibitors: structure-activity relationship (SAR) analysis and preliminary mechanism investigation","volume":"130","author":"Xiao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136332","article-title":"Synthesis, enzyme inhibition and molecular docking studies of pyrazolo[1,5-a][1,3,5] triazine derivatives as potential antioxidant agents","volume":"1294","author":"Raghu","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108486_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133622","article-title":"Synthesis, comparative theoretical and experimental characterization of some new 1,3,5 triazine based heterocyclic compounds and in vitro evaluation as promising biologically active agents","volume":"1268","author":"Noureen","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108486_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2023.108546","article-title":"In silico screening, synthesis, and antimalarial evaluation of PABA substituted 1,3,5-triazine derivatives as pf-DHFR inhibitors","volume":"250","author":"Saha","year":"2023","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioorg.2025.108486_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103239","article-title":"Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors","volume":"92","author":"Oudah","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108486_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4172\/2161-0444.1000255","article-title":"A systematic review on antitumor agents with 1, 3, 5-triazines","volume":"5","author":"Liu","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103525","article-title":"Design, synthesis and biological evaluation of substituted 2-(thiophen-2-yl)-1,3,5-triazine derivatives as potential dual PI3Kalpha\/mTOR inhibitors","volume":"95","author":"Zhang","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108486_bb0260","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/ijms22105207","article-title":"Inhibition of the PI3K\/mTOR pathway in breast Cancer to enhance response to immune checkpoint inhibitors in breast Cancer","volume":"22","author":"Yan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108486_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.115997","article-title":"Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K\/mTOR","volume":"32","author":"Hu","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106157","article-title":"Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): a novel potent dual PI3K\/mTOR inhibitor for cancer therapy","volume":"129","author":"Sun","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tet.2023.133293","article-title":"Design, synthesis and anti-cancer evaluation of genistein-1,3,5-triazine derivatives","volume":"134","author":"Zou","year":"2023","journal-title":"Tetrahedron"},{"issue":"27","key":"10.1016\/j.bioorg.2025.108486_bb0280","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1039\/D4NJ00819G","article-title":"Design, synthesis and anticancer evaluation of imamine-1,3,5-triazine derivatives","volume":"48","author":"Xue","year":"2024","journal-title":"New J. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108486_bb0285","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1002\/cmdc.202100409","article-title":"Synthesis and antimicrobial evaluation of Bis-morpholine Triazine quaternary ammonium salts","volume":"16","author":"Morandini","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108486_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT Signalling pathway in Cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108486_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108486_bb0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2025.108486_bb0305","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/1568009043332763","article-title":"Targeting apoptosis pathways in Cancer therapy","volume":"4","author":"Fulda","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108486_bb0310","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Riedl","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108486_bb0315","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108486_bb0320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acthis.2018.03.007","article-title":"Current methodology of MTT assay in bacteria \u2013 a review","volume":"120","author":"Grela","year":"2018","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108486_bb0330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108486_bb0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","article-title":"Natural product-based nanoformulations for cancer therapy: opportunities and challenges","volume":"69","author":"Kashyap","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2025.108486_bb0340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnci\/58.2.209","article-title":"Absence of HeLa cell contamination in 169 cell lines derived from human tumors","volume":"58","author":"Fogh","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108486_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cels.2019.07.003","article-title":"Kshitiz, Systems Biology of Cancer Metastasis","volume":"9","author":"Suhail","year":"2019","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108486_bb0350","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108486_bb0355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-61779-207-6_8","article-title":"Transwell((R)) invasion assays","volume":"769","author":"Marshall","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108486_bb0360","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","article-title":"Altered cell adhesion and glycosylation promote Cancer immune suppression and metastasis","volume":"10","author":"Laubli","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108486_bb0365","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.108486_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2009.12.092","article-title":"Evaluation of 5-ethynyl-2\u2032-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system","volume":"1319","author":"Zeng","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108486_bb0375","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/cells8050440","article-title":"Patient derived chicken egg tumor model (PDcE model): current status and critical issues","volume":"8","author":"Komatsu","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108486_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12570","article-title":"Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model","volume":"8","author":"Villanueva","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2025.108486_bb0385","doi-asserted-by":"crossref","unstructured":"A. de Cristo Soares Alves, D. Rosane Dallemole, T. Medeiro Ciocheta, A. Ferreira Weber, S. da Silva G\u00fcndel, F. Visioli, F. Figueir\u00f3, S. Stanis\u00e7uaski Guterres, A. Raffin Pohlmann, Chicken embryo model for in vivo acute toxicological and antitumor efficacy evaluation of lipid nanocarrier containing doxorubicin, Int. J. Pharm.:X 6 (2023) 100193.","DOI":"10.1016\/j.ijpx.2023.100193"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108486_bb0390","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.108486_bb0395","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108486_bb0400","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17460441.2012.648612","article-title":"Going further than Lipinski's rule in drug design","volume":"7","author":"Walters","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108486_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17297","article-title":"Optimization of drug scheduling for cancer chemotherapy with considering reducing cumulative drug toxicity","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108486_bb0410","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108486_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130200","article-title":"Identification of ACK1 inhibitors as anticancer agents by using computer-aided drug designing","volume":"1235","author":"Kumar","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108486_bb0420","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s11426-011-4398-4","article-title":"5-Ethynyl-2\u2032-deoxyuridine as a molecular probe of cell proliferation for high-content siRNA screening assay by \u201cclick\u201d chemistry","volume":"54","author":"Chen","year":"2011","journal-title":"Sci. China:Chem."},{"issue":"47","key":"10.1016\/j.bioorg.2025.108486_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203997","article-title":"Design, synthesis, biological evaluation and molecular dynamics simulations study of Genistein-O-1,3,5-Triazine derivatives as multifunctional anti-Alzheimer agents","volume":"7","author":"Zou","year":"2022","journal-title":"ChemistrySelect"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:26:15Z","timestamp":1762223175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":85,"alternative-id":["S0045206825003669"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108486","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, bioactivity, X-ray crystallography, and molecular docking studies of chrysin-1,3,5-triazine derivatives as anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108486"}}